EP1536825A4 - IMMUNOGLOBULIN INTERFERON AND FRAGMENT FC HYBRID - Google Patents

IMMUNOGLOBULIN INTERFERON AND FRAGMENT FC HYBRID

Info

Publication number
EP1536825A4
EP1536825A4 EP02753441A EP02753441A EP1536825A4 EP 1536825 A4 EP1536825 A4 EP 1536825A4 EP 02753441 A EP02753441 A EP 02753441A EP 02753441 A EP02753441 A EP 02753441A EP 1536825 A4 EP1536825 A4 EP 1536825A4
Authority
EP
European Patent Office
Prior art keywords
interferon
immunoglobulin
fragment
hybrid
immunoglobulin interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02753441A
Other languages
German (de)
French (fr)
Other versions
EP1536825A1 (en
Inventor
Tse Wen Chang
Liming Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Priority claimed from PCT/US2002/025154 external-priority patent/WO2004022088A1/en
Publication of EP1536825A1 publication Critical patent/EP1536825A1/en
Publication of EP1536825A4 publication Critical patent/EP1536825A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP02753441A 2002-08-07 2002-08-07 IMMUNOGLOBULIN INTERFERON AND FRAGMENT FC HYBRID Withdrawn EP1536825A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/025154 WO2004022088A1 (en) 1999-10-15 2002-08-07 Interferon and immunoglobulin fc fragment hybrid

Publications (2)

Publication Number Publication Date
EP1536825A1 EP1536825A1 (en) 2005-06-08
EP1536825A4 true EP1536825A4 (en) 2007-09-12

Family

ID=34271615

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02753441A Withdrawn EP1536825A4 (en) 2002-08-07 2002-08-07 IMMUNOGLOBULIN INTERFERON AND FRAGMENT FC HYBRID

Country Status (3)

Country Link
EP (1) EP1536825A4 (en)
AU (1) AU2002313730A1 (en)
CA (1) CA2495480A1 (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
AU2002313730A1 (en) 2004-03-29
EP1536825A1 (en) 2005-06-08
CA2495480A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
EP1572744A4 (en) IMMUNOGLOBULIN VARIANTS AND USES THEREOF
CY2012002I1 (en) HUMAN CTLA-4 ANTIBODIES AND USES THEREOF
ATE549033T1 (en) THERAPEUTIC HUMAN MONOCLONAL ANTI-IL-1R1 ANTIBODY
ATE458008T1 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST CTLA-4
EP1636334A4 (en) Recombinant anti-cd30 antibodies and uses thereof
EP1071458A4 (en) HUMANIZED ANTIBODIES AND ITS USES
FR2844203B1 (en) PARFUMEUR DE AMBIANCE
ATE412013T1 (en) ANTI-OSTEOPONTIN ANTIBODIES AND USE THEREOF
AU2003253621A1 (en) Modified "s" antibodies
EP1558284A4 (en) Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
FR2797298B1 (en) EXHAUST VOLUME
FR2827909B1 (en) EXHAUST MUFFLER
DE60330255D1 (en) THERMOPLASTIC COMPOSITION AND FORM BODY THEREOF
FR2853038B1 (en) SEAL AND REALIMENTATION TRIM
DE60237689D1 (en) Thermoplastic Polyethylene Composition
EP1607711A4 (en) IGNITION ASSEMBLY
DE60203475D1 (en) Throttle and throttle
ID29845A (en) ORAL SERTRALINA CONCENTRATES
FR2837285B1 (en) ULTRASONIC IMAGING PACK
NO20011006D0 (en) High-affinity antibodies
EP1710305A4 (en) FRACTION AND ANTIBODIES CONTAINING COBAYE IMMUNOGLOBULIN E
DE50206175D1 (en) THIOCHROMENONE AGAINST PAIN STATES AND NEURODEEGENERATIVE DISEASES
DE50211073D1 (en) vehicle flap
AU2002313730A1 (en) Interferon and immunoglobulin fc fragment hybrid
FR2836951B1 (en) DOOR VANTAIL EQUIPPED WITH ANTI-CLIP FINGER TRIM AND ANTI-CLIP TRIM FINGERS FOR DOOR FENCE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050304

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20070814

17Q First examination report despatched

Effective date: 20080118

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: GENENTECH, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080729